高级检索
当前位置: 首页 > 详情页

S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]State Key Laboratory of Oncology in South China, CollaborativeInnovation Center for Cancer Medicine, Guangdong Key Laboratoryof Nasopharyngeal Carcinoma Diagnosis and Therapy, Departmentof Nasopharyngeal Carcinoma, Sun Yat-Sen University CancerCenter, Guangzhou 510060, P. R. China [2]Department of Radiation Oncology, Shandong Cancer Hospitaland Institute, Shandong First Medical University and ShandongAcademy of Medical Sciences, Jinan 250117, P. R. China [3]Department of Radiation Oncology, Xiang’an Hospital of XiamenUniversity, School of Medicine, Xiamen University, Xiamen, P. R. China [4]Ningxia Key Laboratory for Cerebrocranical Disease, Ningxia MedicalUniversity, Yinchuan 750001 Ningxia, P. R. China [5]Institute of Gastroenterology, the Sixth Affiliated Hospital of Sun Yat-senUniversity, Guangzhou 510655 Guangdong, P. R. China [6]Department of Traditional Chinese Medicine, the First Affiliated Hospitalof Sun Yat-Sen University, Guangzhou 510080 Guangdong, P. R. China [7]Department of Medical Oncology, Sun Yat-Sen University CancerCenter, Guangzhou 510060, P. R. China [8]Department of Plastic Surgery, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, P. R. China [9]Guangzhou Concord Cancer Center, Guangzhou, P. R. China
出处:
ISSN:

摘要:
Nasopharyngeal carcinoma (NPC) is a unique head and neck cancer with highly aggressive and metastatic potential in which distant metastasis is the main reason for treatment failure. Till present, the underlying molecular mechanisms of NPC metastasis remains poorly understood. Here, we identified S100 calcium-binding protein A14 (S100A14) as a functional regulator suppressing NPC metastasis by inhibiting the NF-kB signaling pathway and reversing the epithelial-mesenchymal transition (EMT). S100A14 was found to be downregulated in highly metastatic NPC cells and tissues. Immunohistochemical staining of 202 NPC samples revealed that lower S100A14 expression was significantly correlated with shorter patient overall survival (OS) and distant metastasis-free survival (DMFS). S100A14 was also found as an independent prognostic factor for favorable survival. Gain- and loss-of-function studies confirmed that S100A14 suppressed the in vitro and in vivo motility of NPC cells. Mechanistically, S100A14 promoted the ubiquitin-proteasome-mediated degradation of interleukin-1 receptor-associated kinase 1 (IRAK1) to suppress NPC cellular migration. Moreover, S100A14 and IRAK1 established a feedback loop that could be disrupted by the IRAK1 inhibitor T2457. Overall, our findings showed that the S100A14-IRAK1 feedback loop could be a promising therapeutic target for NPC metastasis.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 1 区 医学
小类 | 2 区 生化与分子生物学 2 区 细胞生物学 2 区 遗传学 2 区 肿瘤学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 生化与分子生物学 1 区 遗传学 2 区 细胞生物学 2 区 肿瘤学
JCR分区:
出版当年[2018]版:
Q1 ONCOLOGY Q1 GENETICS & HEREDITY Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 CELL BIOLOGY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 CELL BIOLOGY Q1 GENETICS & HEREDITY Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]State Key Laboratory of Oncology in South China, CollaborativeInnovation Center for Cancer Medicine, Guangdong Key Laboratoryof Nasopharyngeal Carcinoma Diagnosis and Therapy, Departmentof Nasopharyngeal Carcinoma, Sun Yat-Sen University CancerCenter, Guangzhou 510060, P. R. China [2]Department of Radiation Oncology, Shandong Cancer Hospitaland Institute, Shandong First Medical University and ShandongAcademy of Medical Sciences, Jinan 250117, P. R. China
共同第一作者:
通讯作者:
通讯机构: [1]State Key Laboratory of Oncology in South China, CollaborativeInnovation Center for Cancer Medicine, Guangdong Key Laboratoryof Nasopharyngeal Carcinoma Diagnosis and Therapy, Departmentof Nasopharyngeal Carcinoma, Sun Yat-Sen University CancerCenter, Guangzhou 510060, P. R. China [9]Guangzhou Concord Cancer Center, Guangzhou, P. R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号